HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Frequently asked questions
What sector does BioTelemetry, Inc (BEAT) operate in?
BioTelemetry, Inc belongs to the Healthcare sector and operates in the Health Information Services industry.
What is BioTelemetry, Inc (BEAT) current stock price?
As of the latest data, BioTelemetry, Inc stock price is $0.50, with a previous close of $0.59. BioTelemetry, Inc lost -$0.09 in the last trading session, representing a -15.34% loss.
What is BioTelemetry, Inc (BEAT) current market capitalization?
BioTelemetry, Inc market cap is approximately 28.14 million.
What is BioTelemetry, Inc (BEAT) Earnings Per Share (EPS)?
The trailing EPS is -$0.44, and the forward EPS is -$0.30.
What is BioTelemetry, Inc (BEAT) EBITDA?
BioTelemetry, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.68 million.
Does BioTelemetry, Inc (BEAT) pay dividends?
No. BioTelemetry, Inc does not pay a dividend.
What is BioTelemetry, Inc (BEAT) beta (volatility) score?
BioTelemetry, Inc has a beta of -0.793, indicating lower volatility than the overall market.
